Kyoto Fusioneering Raises $77 Million to Accelerate R&D, Expand Global Operations
By Kosaku Narioka
Kyoto Fusioneering said Wednesday that it had raised 10.5 billion yen ($77.0 million) to fund research and development of fusion-energy equipment and strengthen its business overseas.
The Japanese fusion-power engineering company said the latest capital infusion brought its total funds raised to Y12.2 billion. The latest funding came from 17 investors, including Japanese oil explorer Inpex, Mitsubishi Corp. and Mitsui & Co., it said.
The company said it would use the proceeds to accelerate research and development for its products, including in-vessel components of fusion reactors, and fusion plant engineering, and expand its business in the U.S. and the U.K. as part of its efforts to commercialize fusion power.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
May 17, 2023 03:12 ET (07:12 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
Will Earnings From These 10 AI Stocks Live Up to the Hype?
-
What’s Happening In the Markets This Week
-
What the Next Bitcoin Halving Means for ETF Investors
-
Going Into Earnings, Is Microsoft a Buy, a Sell, or Fairly Valued?
-
10 Best Blue-Chip Stocks to Buy for the Long Term
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
ServiceNow Earnings: Strong Quarter With In-Line Guidance and Increasingly Attractive Valuation
-
Ford Earnings: Pro Continues to Impress While EV Costs Are Contained
-
Boeing Earnings: Paying for Mistakes Made Long Ago, Taking Back the Factory Floor
-
Meta Earnings: Stock Now Fairly Valued After Latest Selloff
-
March PCE Inflation Index Forecasts Show Mixed Readings On Price Pressures
-
After Earnings, Is Charles Schwab Stock a Buy, a Sell, or Fairly Valued?